Association of Tumor-Infiltrating Lymphocytes (tils) and Immune Signatures with PAM50 Intrinsic Subtyping Hormone Receptor-Positive (Hr+)/her2-Negative (HER2-) Early Breast Cancer (BC): A Translational Analysis of Two Multicentric Neoadjuvant Trials.